Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 49 | 23 | 7 | 13 | 1 |
| Accounts receivable | -36 | 12 | -12 | 89 | -61 |
| Other Working Capital | 618 | 269 | 1,025 | 667 | -419 |
| Other Operating Activity | -1,163 | -1,245 | -2,413 | -2,190 | -1,669 |
| Operating Cash Flow | $-532 | $-941 | $-1,394 | $-1,422 | $-2,149 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 17 | -214 | 0 | -7 | -5 |
| Investing Cash Flow | $17 | $-214 | $0 | $-7 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8 | 28 | N/A | N/A | N/A |
| Common Stock Issued | 15 | 1,451 | 424 | 0 | 2,184 |
| Other Financing Activity | 50 | -161 | -29 | -15 | -115 |
| Financing Cash Flow | $57 | $1,318 | $395 | $-15 | $2,069 |
| Beginning Cash Position | 515 | 351 | 1,350 | 2,793 | 2,878 |
| End Cash Position | 57 | 515 | 351 | 1,350 | 2,793 |
| Net Cash Flow | $-458 | $164 | $-999 | $-1,443 | $-85 |
| Free Cash Flow | |||||
| Operating Cash Flow | -532 | -941 | -1,394 | -1,422 | -2,149 |
| Capital Expenditure | N/A | -214 | N/A | -7 | -5 |
| Free Cash Flow | -532 | -1,155 | -1,394 | -1,428 | -2,154 |